Table 2. Survival status and clinicopathological parameters in 125 human nasopharyngeal carcinoma tissues.
| Clinicopathological parameters | Total | Survival status, n | P | |
|---|---|---|---|---|
| Alive | Dead | |||
| Gender | 1.000 | |||
| Male | 99 | 66 | 33 | |
| Female | 26 | 18 | 8 | |
| Age, yr | 0.826 | |||
| < 50 | 31 | 20 | 11 | |
| ≥ 50 | 94 | 64 | 30 | |
| Smoking | 0.086 | |||
| No | 92 | 66 | 26 | |
| Yes | 33 | 18 | 15 | |
| T classification | 0.507 | |||
| T1–T2 | 96 | 66 | 30 | |
| T3–T4 | 29 | 18 | 18 | |
| N classification | 0.001* | |||
| N0–N1 | 27 | 25 | 2 | |
| N2–N3 | 98 | 59 | 39 | |
| Distant metastasis | 0.000* | |||
| No | 100 | 78 | 22 | |
| Yes | 25 | 6 | 19 | |
| TNM clinical stage | 0.002* | |||
| I–II | 21 | 20 | 1 | |
| III–IV | 104 | 64 | 40 | |
| HAX-1 | 0.017* | |||
| Low expression | 32 | 27 | 5 | |
| High expression | 93 | 57 | 36 | |
Statistical analyses were performed by the Pearson χ2 test. P < 0.05 was considered significant.